Found: 173
Select item for more details and to access through your institution.
Protocol digest of a randomized phase III trial comparing S-1-based chemoradiotherapy with/without nivolumab for unresectable locally advanced or borderline resectable pancreatic cancer: JCOG1908E (PENETRATE).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 11, p. 1214, doi. 10.1093/jjco/hyae084
- By:
- Publication type:
- Article
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 8, p. 880, doi. 10.1093/jjco/hyae052
- By:
- Publication type:
- Article
Protocol of a randomized phase II/III study of gemcitabine plus nab-paclitaxel combination therapy versus modified FOLFIRINOX versus S-IROX for metastatic or recurrent pancreatic cancer: JCOG1611 (GENERATE).
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 80, doi. 10.1093/jjco/hyac146
- By:
- Publication type:
- Article
Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 2, p. 130, doi. 10.1093/jjco/hyac177
- By:
- Publication type:
- Article
Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1105, doi. 10.1093/jjco/hyac110
- By:
- Publication type:
- Article
Management of elderly patients with unresectable pancreatic cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 9, p. 959, doi. 10.1093/jjco/hyac101
- By:
- Publication type:
- Article
Systemic therapy for hepatocellular carcinoma: current status and future perspectives.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 9, p. 1363, doi. 10.1093/jjco/hyab108
- By:
- Publication type:
- Article
Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1185, doi. 10.1093/jjco/hyab076
- By:
- Publication type:
- Article
Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 235, doi. 10.1093/jjco/hyaa198
- By:
- Publication type:
- Article
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1353, doi. 10.1093/jjco/hyaa170
- By:
- Publication type:
- Article
A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancers.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 12, p. 1073, doi. 10.1093/jjco/hyz150
- By:
- Publication type:
- Article
Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD).
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 3, p. 287, doi. 10.1093/jjco/hyy188
- By:
- Publication type:
- Article
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 2, p. 190, doi. 10.1093/jjco/hyy190
- By:
- Publication type:
- Article
New developments in systemic therapy for advanced biliary tract cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 8, p. 703, doi. 10.1093/jjco/hyy082
- By:
- Publication type:
- Article
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 317, doi. 10.1093/jjco/hyy010
- By:
- Publication type:
- Article
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 392, doi. 10.1093/jjco/hyy004
- By:
- Publication type:
- Article
Chemotherapy for hepatocellular carcinoma: current status and future perspectives.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 2, p. 103, doi. 10.1093/jjco/hyx180
- By:
- Publication type:
- Article
Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 9, p. 832, doi. 10.1093/jjco/hyx075
- By:
- Publication type:
- Article
A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 6, p. 512, doi. 10.1093/jjco/hyx038
- By:
- Publication type:
- Article
Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT).
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 4, p. 385, doi. 10.1093/jjco/hyv213
- By:
- Publication type:
- Article
Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 5, p. 439, doi. 10.1093/jjco/hyv011
- By:
- Publication type:
- Article
EBM-based Clinical Guidelines for Pancreatic Cancer (2013) Issued by the Japan Pancreas Society: A Synopsis.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 10, p. 883, doi. 10.1093/jjco/hyu127
- By:
- Publication type:
- Article
Axitinib (AG-013736), an Oral Specific VEGFR TKI, Shows Potential Therapeutic Utility Against Cholangiocarcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 6, p. 570, doi. 10.1093/jjco/hyu045
- By:
- Publication type:
- Article
Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion.
- Published in:
- Liver International, 2010, v. 30, n. 10, p. 1427, doi. 10.1111/j.1478-3231.2010.02292.x
- By:
- Publication type:
- Article
Biomarker Analyses in Patients With Advanced Solid Tumors Treated With the LAT1 Inhibitor JPH203.
- Published in:
- In Vivo, 2020, v. 34, n. 5, p. 2595, doi. 10.21873/invivo.12077
- By:
- Publication type:
- Article
Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 8, p. 1170, doi. 10.3390/jcm8081170
- By:
- Publication type:
- Article
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial).
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 11/12, p. 988, doi. 10.1159/000505550
- By:
- Publication type:
- Article
Sorafenib for the treatment of unresectable hepatocellular carcinoma.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 4, p. 779
- By:
- Publication type:
- Article
Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2008, v. 15, n. 4, p. 1008, doi. 10.1245/s10434-007-9705-0
- By:
- Publication type:
- Article
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0298420
- By:
- Publication type:
- Article
The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemotherapy: A Prospective Observational Study.
- Published in:
- Internal Medicine, 2023, v. 62, n. 11, p. 1573, doi. 10.2169/internalmedicine.9689-22
- By:
- Publication type:
- Article
A Prospective Study of Neoadjuvant Gemcitabine Plus Nab-paclitaxel in Patients with Borderline-resectable Pancreatic Cancer.
- Published in:
- Internal Medicine, 2023, v. 62, n. 3, p. 327, doi. 10.2169/internalmedicine.9504-22
- By:
- Publication type:
- Article
Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study.
- Published in:
- BMC Cancer, 2020, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12885-020-07462-4
- By:
- Publication type:
- Article
Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 6, p. 777, doi. 10.1007/s10637-023-01399-8
- By:
- Publication type:
- Article
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1495, doi. 10.1007/s10637-020-00924-3
- By:
- Publication type:
- Article
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 445, doi. 10.1007/s10637-019-00780-w
- By:
- Publication type:
- Article
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 507, doi. 10.1007/s10637-018-0697-3
- By:
- Publication type:
- Article
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1072, doi. 10.1007/s10637-018-0658-x
- By:
- Publication type:
- Article
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1058, doi. 10.1007/s10637-015-0270-2
- By:
- Publication type:
- Article
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 456, doi. 10.1007/s10147-024-02467-6
- By:
- Publication type:
- Article
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 188, doi. 10.1007/s10147-023-02432-9
- By:
- Publication type:
- Article
Treatments for elderly cancer patients and reforms to social security systems in Japan.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 310, doi. 10.1007/s10147-021-02099-0
- By:
- Publication type:
- Article
Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 5, p. 894, doi. 10.1007/s10147-018-1283-6
- By:
- Publication type:
- Article
Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 127, doi. 10.1007/s10147-007-0739-x
- By:
- Publication type:
- Article
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines).
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 383, doi. 10.1111/hepr.13892
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version).
- Published in:
- Hepatology Research, 2022, v. 52, n. 4, p. 329, doi. 10.1111/hepr.13746
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version).
- Published in:
- Hepatology Research, 2019, v. 49, n. 9, p. 981, doi. 10.1111/hepr.13394
- By:
- Publication type:
- Article
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version).
- Published in:
- Hepatology Research, 2016, v. 46, n. 1, p. 3, doi. 10.1111/hepr.12542
- By:
- Publication type:
- Article
Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents.
- Published in:
- Hepatology Research, 2015, v. 45, n. 12, p. 1220, doi. 10.1111/hepr.12496
- By:
- Publication type:
- Article